LifeStance Health Group annual ebitda margin
2019
2021
2022
2023
2024
2025
LifeStance Health Group EBITDA Margin Growth & History (LFST)
LifeStance Health Group's ebitda margin was 4.62% for fiscal 2025.
View full LifeStance Health Group company overviewLifeStance Health Group annual ebitda margin history
| Fiscal year | Period ended | EBITDA margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 4.62% | +3.89 pp |
| 2024 | 2024-12-31 | 0.72% | +15.10 pp |
| 2023 | 2023-12-31 | −14.38% | +6.71 pp |
| 2022 | 2022-12-31 | −21.09% | +18751.16 pp |
| 2021 | 2021-12-31 | −18,772.25% | — |
| 2019 | 2019-12-31 | 8.60% | — |
LifeStance Health Group quarterly ebitda margin
Q2.20
Q3.20
Q1.21
Q2.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | EBITDA margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 9.64% | +7.41 pp |
| Q1 2026 | 2026-03-31 | 8.09% | +4.52 pp |
| Q4 2025 | 2025-12-31 | 7.44% | +4.00 pp |
| Q3 2025 | 2025-09-30 | 4.88% | +1.54 pp |
| Q2 2025 | 2025-06-30 | 2.23% | +4.09 pp |
| Q1 2025 | 2025-03-31 | 3.57% | +5.82 pp |
| Q4 2024 | 2024-12-31 | 3.43% | +11.49 pp |
| Q3 2024 | 2024-09-30 | 3.34% | +28.03 pp |
| Q2 2024 | 2024-06-30 | −1.86% | +13.18 pp |
| Q1 2024 | 2024-03-31 | −2.25% | +7.73 pp |
| Q4 2023 | 2023-12-31 | −8.05% | +8.19 pp |
| Q3 2023 | 2023-09-30 | −24.69% | −10.37 pp |
| Q2 2023 | 2023-06-30 | −15.05% | +10.59 pp |
| Q1 2023 | 2023-03-31 | −9.98% | +19.14 pp |
| Q4 2022 | 2022-12-31 | −16.24% | — |
| Q3 2022 | 2022-09-30 | −14.32% | — |
| Q2 2022 | 2022-06-30 | −25.64% | +3217.35 pp |
| Q1 2022 | 2022-03-31 | −29.11% | −30.32 pp |
| Q2 2021 | 2021-06-30 | −3,242.99% | −8661.74 pp |
| Q1 2021 | 2021-03-31 | 1.21% | — |
| Q3 2020 | 2020-09-30 | 9,865.91% | — |
| Q2 2020 | 2020-06-30 | 5,418.75% | — |
LifeStance Health Group ebitda margin trends
Between the periods ended 2019-12-31 and 2025-12-31, LifeStance Health Group's ebitda margin decreased from 8.60% to 4.62%, a change of −3.98 percentage points. The latest reported quarter, Q2 2026, shows 9.64%.
About the metric
What EBITDA margin means
EBITDA margin measures EBITDA as a percentage of revenue. It can help compare operating profitability over time, but it excludes capital intensity, financing costs, taxes, and other items and is generally unsuitable for financial companies.
Calculation and source
How EBITDA margin is calculated
TickerStat calculates EBITDA margin as EBITDA divided by positive reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review LifeStance Health Group source filings ↗